Yeh, Y.-C., Lin, T.-F., Lin, F.-S., Wang, Y.-P., Lin, C.-J. and Sun, W.-Z. (2008) Combination of Opioid Agonist and Agonist-Antagonist: Patient-Controlled Analgesia Requirement and Adverse Events among Different-Ratio Morphine and Nalbuphine Admixtures for Postoperative Pain. British Journal of Anaesthesia, 101, 542-548.
http://dx.doi.org/10.1093/bja/aen213

has been cited by the following article:

• TITLE: Effect of Nalbuphine as Adjuvant to Bupivacaine for Ultrasound-Guided Supraclavicular Brachial Plexus Block

  AUTHORS: Mohamed Mohamed Abdelhaq, Mohamed Adly Elramely

  KEYWORDS: Supraclavicular Block, Local Anesthetic, Ultrasound, Nalbuphine

  JOURNAL NAME: Open Journal of Anesthesiology, Vol.6 No.3, March 17, 2016

  ABSTRACT: Background: Nalbuphine is a derivative of 14-hydroxymorphine which is a strong analgesic with mixed k agonist and μ antagonist. Nalbuphine was studied several times as adjuvant to local anesthetics in spinal, epidural and local intravenous block. The aim of this study was to evaluate the effect of nalbuphine as an adjuvant to local anesthetics in supraclavicular brachial plexus block. Patients and Methods: Fifty-six patients undergoing elective forearm and hand surgery under supraclavicular brachial plexus block were allocated randomly into one of two groups of 28 patients each to receive either 25 ml (0.5%) bupivacaine with 1 ml of NS or 25 ml (0.5%) bupivacaine with 1 ml (20 mg) nalbuphine. Onset time and duration of both sensory and motor block, and post-operative analgesia were observed. Result: Nalbuphine group showed significant increase in the duration of motor block (412.59 ± 18.63), when compared to control group (353.70 ± 29.019) p-value